Gelenkschwellungen, reversible Armparese und erhöhtes Serum-IgG4 bei einem 55-jährigen Patienten

Bonekamp D et al (2011) Castleman disease: the great mimic. Radiographics 31:1793–1807

Deshpande V et al (2012) Consensus statement on the pathology of IgG4-related disease. Mod Pathol 25:1181–1192

Kawano M et al (2011) Proposal for diagnostic criteria for IgG4-related kidney disease. Clin Exp Nephrol 15:615–626

Khosroshahi A et al (2010) Rituximab therapy leads to rapid decline of serum IgG4 levels and prompt clinical improvement in IgG4-related systemic disease. Arthritis Rheum 62:1755–1762

Khosroshahi A, Stone JH (2011) A clinical overview of IgG4-related systemic disease. Curr Opin Rheumatol 23:57–66

Khosroshahi A, Stone JH (2011) Treatment approaches to IgG4-related systemic disease. Curr Opin Rheumatol 23:67–71

Lin G, Li J (2010) Elevation of serum IgG subclass concentration in patients with rheumatoid arthritis. Rheumatol Int 30:837–840

Rispens T et al (2011) Mechanism of immunoglobulin G4 Fab-arm exchange. J Am Chem Soc 133:10302–10311

Sah RP et al (2010) Differences in clinical profile and relapse rate of type 1 versus type 2 autoimmune pancreatitis. Gastroenterology 139:140–148

Sato Y, Yoshino T (2012) IgG4-Related Lymphadenopathy. Int J Rheumatol 2012:572539

Stone JH, Zen Y, Deshpande V (2012) IgG4-related disease. N Engl J Med 366:539–551

Umehara H et al (2012) A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details. Mod Rheumatol 22:1–14

Yamamoto M et al (2012) Relapse patterns in IgG4-related disease. Ann Rheum Dis 71:1755